Diamyd Medical AB: Annual Report 10/11

Published: Dec 09, 2011

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

Q1

• Results from Phase I study in cancer pain shows promising safety data and relief of chronic pain

Q2 • Recruitment for US Phase III study in type 1 diabetes is completed • Phase II study in cancer pain is started • University of Florida Research Foundation initiates court case against Diamyd Medical (STO:DIAM.B)

Back to news